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S U M M A R Y
Introduction: We conducted this study to determine the frequency of malaria and dengue–malaria co-
infection in patients admitted to our hospital as ‘probable’ cases of dengue fever during the 2012
outbreak of dengue, and to ascertain whether dengue–malaria co-infection was more severe than either
infection alone.
Methods: This cross-sectional observational study was conducted at Jinnah Hospital Lahore, Pakistan
between August and November 2012. Patients with 2–10 days of fever and with two or more of the
following: myalgia, arthralgia, retro-orbital pain, headache, skin rash, and hemorrhagic manifestations
plus thrombocytopenia and leukopenia, were classiﬁed as probable cases of dengue fever and were
subjected to reverse transcriptase (RT)-PCR and/or dengue-speciﬁc IgM by ELISA. The diagnosis of
malaria was established on thick and thin blood ﬁlm microscopy. Severe disease was deﬁned by the
presence of an altered level of consciousness, World Health Organization grade 2 bleeding, jaundice,
circulatory shock, hemoglobin <50 g/l, platelet count <50  109/l, serum creatinine >265 mmol/l, or
death.
Results: There were 85 probable cases of dengue fever. Sixty-four (75%) were male and the median age
was 22 years (range 12–90 years). Of 52 patients for whom results of diagnostic tests for both dengue and
malaria were available, ﬁve (10%) had isolated dengue infection, 18 (35%) isolated Plasmodium infection,
and 17 (33%) dengue–malaria co-infection. Thirty-ﬁve out of 52 (67%) probable cases had malaria and 17
out of 22 (77%) dengue-speciﬁc IgM reactive patients had concurrent malaria. Patients with isolated
malaria had signiﬁcantly lower median hemoglobin concentrations (124.5 g/l vs. 144.0 g/l, p = 0.04) and
median hematocrit (36.0 vs. 41.7, p = 0.02) at presentation than cases of isolated dengue. Patients with
dengue–malaria co-infection had a signiﬁcantly lower rate of jaundice than those with isolated dengue
(0% vs. 40%, p = 0.04). The frequency of severe disease was comparable amongst the three groups; this
was seen in ﬁve (100%) cases of isolated dengue, 17 (94%) cases of isolated malaria, and 16 (94%) cases of
dengue–malaria co-infection.
Conclusions: The rate of isolated malaria and dengue–malaria co-infection was high in probable cases of
dengue fever in our study. Except for jaundice, we could not ﬁnd any signiﬁcant between-group
differences in the severity of the disease.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Dengue and malaria are two of the most important mosquito-
borne diseases worldwide. The true burden of these two diseases is       
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to be 390 million infections per year, an infection total more than
three times the estimates of the World Health Organization
(WHO).1 Many tropical and sub-tropical countries are endemic for
both dengue and malaria. The two diseases share many clinical
features and may be clinically indistinguishable. It is important,
however, to differentiate between the two conditions, as malaria is
treatable and any delay in treatment may result in a poor outcome.
There are few published reports on concurrent dengue and malaria
infection. The reported frequencies of concurrent infection in
febrile patients presenting to outpatient departments of hospitalsociety for Infectious Diseases. Open access under CC BY-NC-ND license.
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Figure 1. Algorithm for selection and admission of probable cases of dengue fever.
On presentation to the outpatient department, a diagnosis of suspected dengue
infection is made on the basis of clinical features. All suspected cases undergo a
complete blood count analysis. Patients with thrombocytopenia and leukopenia are
classiﬁed as probable cases of dengue fever and admitted to the dedicated dengue
ward. Patients who do not fulﬁll the criteria for probable cases are followed in the
outpatient department after 24 h. All probable cases of dengue fever undergo
speciﬁc diagnostic testing depending on the day of illness.
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French Guiana2 to 6% in India3 and 27% in Pakistan.4 However,
these studies differ greatly in terms of patient selection criteria and
methods used for the diagnosis of dengue infection. There are also
conﬂicting reports on whether dengue–malaria co-infection is
more severe than either infection alone.3,5
Pakistan is endemic for malaria, whereas dengue has estab-
lished itself in an epidemic transmission cycle. The largest
outbreak of dengue in Pakistan was observed in 2011 in Punjab.
In the setting of outbreaks in a resource-limited country, it is not
cost-effective to subject all febrile patients to speciﬁc diagnostic
testing for dengue. The Dengue Expert Advisory Group (DEAG)
Punjab, a committee of expert clinicians, pathologists, and public
health professionals, was established to develop recommendations
and guidelines for the prevention and management of dengue fever
at the provincial level. The DEAG has issued guidelines wherein
stringent clinical and laboratory criteria are used to select
‘probable’ cases of dengue fever who may then be subjected to
speciﬁc tests for dengue infection. Although this stringent case
deﬁnition may give a sense of high speciﬁcity for selecting cases of
dengue infection, the clinical and laboratory parameters are non-
speciﬁc and may also be observed in cases of malaria. In malaria
endemic settings it is, therefore, important to ascertain the
frequency of malaria infection in patients categorized as probable
cases of dengue fever. There is a risk of misdiagnosing cases of
malaria as cases of dengue infection in the setting of a dengue
outbreak, as the two diseases share many clinical and laboratory
characteristics. The late recognition and treatment of malaria is
associated with a poor outcome. This holds especially true for
patients who have a dengue–malaria co-infection and in whom the
conﬁrmation of dengue may lead clinicians to overlook a
concurrent malaria infection.
We analyzed the data of patients admitted to the dengue ward
of our hospital during the 2012 outbreak of dengue fever to
determine the frequency of isolated malaria and dengue–malaria
co-infection in patients categorized as probable cases of dengue
fever, and to ascertain whether dengue–malaria co-infection was
more severe than either infection alone.
2. Methods
In this cross-sectional observational study, we analyzed the
data of probable cases of dengue fever admitted to the dengue
ward of Jinnah Hospital Lahore between August and November
2012. Jinnah Hospital Lahore is a 1200-bed tertiary care hospital
that has a fever clinic and a dedicated dengue ward established
during dengue outbreaks for the screening and admission of cases
of dengue fever. The guidelines for classiﬁcation, diagnosis,
admission, and management are issued by the DEAG Punjab.
These guidelines are a modiﬁcation of the 2011 WHO Regional
Ofﬁce for South-East Asia (WHO SEARO) guidelines for the
management of dengue fever.6 The process of evaluation at the
fever clinic and admission to the dengue ward is described below
and summarized in Figure 1.
Patients with fever of 2–10 days of duration with two or more of
the following are classiﬁed as ‘suspected’ cases of dengue fever:
myalgia, arthralgia, retro-orbital pain, headache, skin rash, and
hemorrhagic manifestations. All suspected case patients are
subjected to a complete blood count analysis using an automated
analyzer that is available in the fever clinic; results are available in
less than an hour. Patients with thrombocytopenia (platelet count
<100  109/l, or a declining trend on serial blood count analysis)
and leukopenia (leukocyte count <4  109/l, or a declining trend
on serial blood count analysis) are classiﬁed as ‘probable’ cases of
dengue fever. All probable cases are admitted to the dengue ward
and are subjected to speciﬁc diagnostic testing for dengueinfection. Patients presenting within 5 days of the onset of illness
undergo reverse transcriptase (RT)-PCR for dengue virus (DENV)
RNA detection, or ELISA for non-structural protein 1 (NS1) antigen
detection. Patients presenting more than 5 days after the onset of
illness undergo ELISA for dengue-speciﬁc IgM. Anti-dengue IgM
antibodies were measured by indirect IgM ELISA using a
commercially available kit (Human GmbH, Wiesbaden, Germany).
This method uses dengue-speciﬁc antigens (DEN-Ag) coated on
microtiter wells. (RT-PCR was also performed on a few patients
after day 5 if they were febrile at the time of admission.) Patients
who test positive for any of these speciﬁc tests are reported as
‘conﬁrmed’ cases of dengue fever. All suspected, probable, and
conﬁrmed cases are reported on an online dashboard established
by the Punjab Information Technology Board (PITB) and data are
available for monitoring the outbreak.
During 2012, we also evaluated all adult probable cases of
dengue fever who were febrile at the time of admission for
Figure 2. Results of speciﬁc diagnostic testing for dengue and malaria. Out of 856 suspected cases, 85 were probable cases of dengue fever and were hospitalized. ELISA for
dengue-speciﬁc IgM was performed in all 85 probable cases. The results of diagnostic tests for both dengue and malaria were available for 52 (61%) probable cases. Of these 52
patients, ﬁve (10%) had isolated dengue infection, 18 (35%) isolated Plasmodium infection, and 17 (33%) dengue–malaria co-infection.
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senior hematologist examined 200 ﬁelds of Giemsa-stained thick
blood smears at 1000 magniﬁcation under immersion oil. The
Plasmodium species were identiﬁed. However, data on asexual
parasitemia were lacking. At least two blood smears were
examined from blood collected 12–24 h apart before reporting a
result negative for malaria.
Patients with isolated dengue infection were treated with
acetaminophen and symptomatic therapy. Patients with an
uncomplicated Plasmodium vivax infection were given the
standard dose of oral chloroquine, followed by the administration
of primaquine after ruling out the contraindications. Patients with
a Plasmodium falciparum infection and/or complicated malaria
were treated with the standard dose of artemether–lumefantrine.
Patients received intravenous ﬂuids and blood transfusions when
clinically indicated.
Severe disease was deﬁned by the presence of any of the
following: altered level of consciousness, multiple convulsions
(more than two episodes in 24 h), WHO grade 2 or higher
spontaneous bleeding, pulmonary edema, circulatory collapse or
shock (pulse pressure 20 mmHg, systolic blood pressure
<90 mmHg), hypoglycemia (blood glucose <2.2 mmol/l, or
<40 mg/dl), metabolic acidosis (plasma bicarbonate <15 mmol/
l), severe normocytic anemia (hemoglobin <50 g/l, packed cell
volume <15%), platelet count <50 109/l, jaundice (serum total
bilirubin >2.5 mg/dl, or >43 mmol/l), renal impairment (serum
creatinine >3 mg/dl, or >265 mmol/l), and death.
The data of all adult probable cases of dengue fever admitted to
the dengue ward were evaluated retrospectively. Patients were
included in the analysis if the results of diagnostic tests for both
dengue and malaria were available. The clinical, laboratory, and
treatment data were abstracted on a standardized form. Data were
analyzed using SPSS software v. 17 (SPSS Inc., Chicago, IL, USA).
Frequencies for isolated dengue, isolated malaria, and dengue–
malaria co-infection were calculated. A comparison was made
between three groups: isolated dengue, isolated malaria, anddengue–malaria co-infection. Patient characteristics were com-
pared using Fisher’s exact test for categorical variables and non-
parametric tests (Kruskal–Wallis and Mann–Whitney U-test) for
continuous variables. A p-value of <0.05 was considered signiﬁ-
cant at a conﬁdence interval of 95%.
3. Results
Out of 856 suspected cases, 85 were probable cases of dengue
fever and were hospitalized. Sixty-four (75%) were male and the
median age was 22 years (range 12–90 years). RT-PCR was
performed on febrile phase serum for 15 patients and was positive
in three patients (the serotype in these cases was DENV-2), while
ELISA for NS1 was performed for an additional two patients and
was reactive in one patient. ELISA for dengue-speciﬁc IgM was
performed for all 85 probable cases and was positive in 37 (43%).
The results of diagnostic tests for both dengue and malaria were
available for 52 (61%) probable cases. Of these 52 patients, ﬁve
(10%) had isolated dengue infection, 18 (35%) isolated Plasmodium
infection, and 17 (33%) dengue–malaria co-infection (Figure 2).
Thirty-ﬁve out of 52 (67%) probable cases had malaria and 17 out of
22 (77%) dengue-speciﬁc IgM reactive patients had a concurrent
infection with Plasmodium. The characteristics of patients for
whom the results of microscopy were available or not available
were comparable.
The results of both direct (RT-PCR, NS1) and indirect methods
(IgM by ELISA) for the diagnosis of dengue infection were available
for 17 patients. Four patients were RT-PCR/NS1- as well as IgM-
positive and Plasmodium-negative (isolated dengue infection).
Two patients tested negative for RT-PCR/NS1, IgM, and Plasmodi-
um (non-dengue, non-malaria). Eleven patients were RT-PCR-
negative, IgM-positive, and Plasmodium-positive.
A comparison of demographics and clinical features, is shown
in Table 1. Patients with dengue–malaria co-infection had a
signiﬁcantly lower rate of jaundice than those with isolated
dengue (0% vs. 40%, p = 0.04). Patients with dengue–malaria
Table 1
Comparison of the clinical proﬁle of cases of isolated dengue, isolated malaria, and dengue–malaria co-infectiona
Isolated dengue (D)
(n = 5)
p-Value
D vs. M
Isolated malaria (M)
(n = 18)
p-Value
M vs. DM
Dengue–malaria co-infection (DM)
(n = 17)
p-Value
DM vs. D
Gender male 4 (80) 0.6 13 (72) 0.45 11 (65) 0.48
Age, years
Median 18 0.08 23.5 0.76 22 0.12
Range 16–22 12–48 12–32
Intermittent fever, yes 4 (80) 0.41 11 (61) 0.55 11 (65) 0.48
Rigors and chills 5 (100) 0.46 15 (83) 0.12 17 (100) 1.0
Myalgia 4 (80) 0.65 15 (83) 0.46 13 (76.5) 0.69
Headache 4 (80) 0.61 13 (72) 0.60 12 (71) 0.58
Retro-orbital pain 2 (40) 0.67 7 (39) 0.27 4 (23) 0.42
Vomiting 3 (60) 0.49 13 (72) 0.32 10 (59) 0.68
Petechiae 0 (0) 0.78 1 (6) 0.28 3 (18) 0.44
Gum bleeding 0 (0) 0.78 1 (6) 0.74 1 (6) 0.77
Epistaxis 1 (20) 0.39 1 (6) 0.74 1 (6) 0.41
Hematemesis 0 (0) 0.46 3 (17) 0.32 1 (6) 0.77
Melena 1 (20) 0.54 2 (11) 0.47 3 (18) 0.67
Macroscopic hematuria 1 (20) 0.39 1 (6) 0.28 3 (18) 0.67
Altered mental status 0 (0) 0.78 1 (6) 0.51 0 (0) 1.00
Abdominal pain 1 (20) 0.32 8 (44) 0.56 7 (41) 0.38
Clinical hepatomegaly 1 (20) 0.39 1 (6) 0.15 4 (23) 0.69
Clinical splenomegaly 0 (0) 1.00 0 (0) 0.10 3 (18) 0.44
Pallor 3 (60) 0.37 7 (40) 0.50 8 (47) 0.45
Jaundice 2 (40) 0.39 4 (22) 0.06 0 (0) 0.04
Hypotension 0 (0) 0.78 1 (6) 0.48 2 (12) 0.59
a Results are n (%) unless stated otherwise.
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malaria group, however this difference was not statistically
signiﬁcant (0% vs. 22%, p = 0.06). The other clinical manifestations
were comparable.
Patients with isolated malaria had a signiﬁcantly lower median
hemoglobin concentration (124.5 g/l vs. 144.0 g/l, p = 0.04) and
median hematocrit (36.0 vs. 41.7, p = 0.02) at presentation than
cases of isolated dengue (Table 2). Patients with dengue–malaria
co-infection also had a lower median hemoglobin concentration
(130.0 g/l vs. 144.0 g/l) and hematocrit (39.3 vs. 41.7) at
presentation than patients with isolated dengue, however the
difference was not statistically signiﬁcant (p = 0.09 and p = 0.07,
respectively).
The frequency of severe disease was comparable amongst the
three groups; this was seen in ﬁve (100%) cases of isolated dengue,
17 (94%) cases of isolated malaria, and 16 (94%) cases of dengue–
malaria co-infection. The comparison of individual determinants of
severe disease is presented in Table 3. All patients recovered and
were discharged from the hospital.
4. Discussion
Our study showed that 35 out of 52 (67%) probable cases of
dengue fever had malaria and 17 out of 22 (77%) dengue-speciﬁc
IgM reactive patients had concurrent malaria. DENV-2 was theTable 2
Comparison of the laboratory proﬁle of cases of isolated dengue, isolated malaria, and
Isolated dengue (D)
(n = 5)
p-Value
D vs. M
Hemoglobin at presentation, g/l 144.0 (132.0–147.0) 0.04 
Lowest hemoglobin g/l 108.0 (96.0–119.0) 0.93 
Hematocrit at presentation 41.7 (41.4–42.8) 0.02 
Lowest hematocrit 33.1 (27.3–35.3) 0.46 
WBC ( 109/l) at presentation 4.65 (1.20–9.30) 0.93 
Lowest WBC ( 109/l) 2.50 (1.10–6.70) 0.56 
Platelet count at presentation ( 109/l) 25.5 (19.0–54.0) 0.29 
Lowest platelet count ( 109/l) 16.5 (13.0–21.0) 0.53 
WBC, white blood cell count.
a Results are the median (range).serotype in three patients who tested positive on RT-PCR. The
percentages of cases of isolated dengue, isolated malaria, and
dengue–malaria co-infection in probable cases of dengue fever
were 10%, 35%, and 33%, respectively. Patients with isolated
malaria had a signiﬁcantly lower hemoglobin concentration and
hematocrit at presentation than cases of isolated dengue. Patients
with dengue–malaria co-infection had a signiﬁcantly lower rate of
jaundice than those with isolated dengue. The remaining clinical
and laboratory parameters were comparable. There was no
between-group difference in terms of severity of the disease.
The ﬁrst case of concurrent DENV and P. falciparum was
reported in 2005,7 and this was followed by reports of mixed
infections with DENV and P. vivax,8 P. falciparum, or both. Abbasi
et al. from Pakistan reported concurrent dengue and malaria
infection in 26 of 112 (23%) febrile patients evaluated for dengue at
a hospital in Karachi.4 Carme et al. evaluated 1723 consecutive
febrile patients in Cayenne Hospital, French Guiana, and found
dengue in 238 (13.8%), malaria in 393 (22.8%), and mixed dengue
and malaria infection in 17 (1%) patients.2 P. vivax was the
predominant Plasmodium species. Mohapatra et al. found dengue–
malaria co-infection in 27 of 469 (5.7%) febrile patients tested for
dengue and malaria in Odisha, India.3 Isolated dengue and malaria
were seen in 340 (72.5%) and 102 (21.7%) patients, respectively. P.
falciparum was the predominant Plasmodium species found. Rapid
diagnostic tests were used for the detection of IgM and NS1 for dengue–malaria co-infectiona
Isolated malaria (M)
(n = 18)
p-Value
M vs. DM
Dengue–malaria
co-infection (DM)
(n = 17)
p-Value
DM vs. D
124.5 (72.0–160.0) 0.95 130.0 (83.0–158.0) 0.09
109.0 (64.0–136.0) 0.99 114.0 (68.0–130.0) 0.93
36.0 (28.1–43.7) 0.69 39.3 (26.0–46.4) 0.07
31.0 (23.7–38.0) 0.50 31.4 (19.6–38.4) 0.95
4.25 (1.30–8.60) 0.46 3.70 (1.60–9.50) 0.79
3.10 (1.30–4.50) 0.59 2.80 (1.40–6.60) 0.93
46.0 (9.0–179.0) 0.35 54.0 (15.0–173.0) 0.12
19.0 (5.0–64.0) 0.99 22.0 (2.0–57.0) 0.45
Table 3
Comparison of individual parameters of severity in cases of isolated dengue, isolated malaria, and dengue–malaria co-infectiona
Isolated dengue (D)
(n = 5)
p-Value
D vs. M
Isolated malaria (M)
(n = 18)
p-Value
M vs. DM
Dengue–malaria
co-infection (DM)
(n = 17)
p-Value
DM vs. D
Altered level of consciousness 0 (0) 0.78 1 (6) 0.51 0 (0) 1.00
Hypotension 0 (0) 0.78 1 (6) 0.48 2 (12) 0.59
WHO grade 2 bleeding 0 (0) 0.46 3 (17) 0.31 5 (29) 0.23
Platelet count <50 000  109/l 4 (80) 0.54 16 (89) 0.52 16 (94) 0.41
Serum creatinine >265 mmol/l 0 (0) 0.78 1 (6) 0.51 0 (0) 1.00
Serum bilirubin >43 mmol/l 2 (40) 0.39 4 (22) 0.06 0 (0) 0.04
Death 0 (0) 1.00 0 (0) 1.00 0 (0) 1.00
WHO, World Health Organization.
a Results are n (%).
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low speciﬁcity of rapid diagnostic tests for IgM,9 there may have
been an over-estimation of the dengue–malaria co-infection
rate. The results of these and other studies may not be
comparable due to the variable patient selection criteria and
diagnostic methods used.
Our study shows that the rate of malaria infection was higher
than the rate of dengue infection in patients admitted as probable
cases of dengue fever. Even amongst the conﬁrmed cases of dengue
infection, there were more cases of dengue–malaria co-infection
than isolated dengue infection. The results of this study cannot be
generalized as we only analyzed a sample of febrile patients selected
through application of a strict operational case deﬁnition. However,
our ﬁndings underscore the importance of testing for malaria
infection even when the likelihood of a dengue infection is high or a
dengue infection is conﬁrmed. Whereas the management of dengue
infection is symptomatic, malaria is a treatable disease and the early
institution of treatment can decrease the risk of complications. The
DEAG algorithm was developed to select cases more likely to have a
dengue infection. Our ﬁndings suggest that this algorithm for the
selection of probable cases of dengue fever did not help differentiate
between dengue and malaria infection. Dengue and malaria share
many clinical and laboratory characteristics, and speciﬁc diagnostic
testing is required to establish the diagnosis.
One of the limitations of our study is that RT-PCR and NS1
testing as direct evidence of dengue infection was available for
only 17 patients, while dengue-speciﬁc IgM as indirect evidence of
dengue infection was used in all 85 patients. Unlike the
immunochromatographic method for the detection of IgM, which
has a low speciﬁcity and high false-positivity,9,10 ELISA for the
detection of IgM has been reported to have a high speciﬁcity
(approximately 98%).10 RT-PCR has the highest diagnostic yield
during the early phase of illness and its sensitivity decreases over
time during the course of illness. A serological diagnosis is helpful
in patients who present later in the course of their illness. Out of
17 patients for whom the results of both direct and indirect
diagnostic tests for dengue were available, there were 11 RT-PCR-
negative IgM-positive patients who tested positive for Plasmodi-
um. There are three possible explanations for these cases: (1)
Patients had a current dengue infection but they were tested by
RT-PCR later in the course of their illness when only IgM
antibodies were detectable. (2) Patients had had a dengue
infection in the recent past (last 2–3 months) and were not
currently infected with dengue. Despite a high speciﬁcity of IgM
by ELISA for dengue,10 once detectable, IgM antibodies may
persist in the serum of infected patients for 2–3 months.
Therefore, although a reliable marker of recent infection with
dengue, a single positive IgM does not necessarily imply a
concurrent dengue infection. This limits its utility in conﬁrming a
dengue–malaria co-infection. (3) Patients had a false-positive IgM
due to malaria. This latter point is less likely given the high
speciﬁcity of ELISA for dengue-speciﬁc IgM.10Except for jaundice being more common in cases of isolated
dengue and malaria than in dengue–malaria co-infection, we did
not ﬁnd a statistically signiﬁcant between-group difference in
terms of severity of the disease using the predeﬁned criteria. A
potential confounder could be the pooling of Plasmodium species
while analyzing the severity indices across the groups, as P.
falciparum is known to cause more severe disease than P. vivax.
Since the frequency of P. falciparum infection was comparable
between the isolated malaria and dengue–malaria co-infection
groups in our study, it is less likely to have confounded our results.
Mohapatra et al. reported signiﬁcantly less severe disease in cases
of dengue–malaria co-infection, presumably due to early presen-
tation to the health facility.3 Epelboin et al., on the other hand,
found signiﬁcantly more severe disease in cases of dengue–
malaria co-infection in a retrospective matched-pair study in
French Guiana.5 In that study, the malaria was caused predomi-
nantly by P. vivax as compared to P. falciparum in the study by
Mohapatra et al. in India. Patients with the co-infection had a
greater risk of deep thrombocytopenia and anemia. These
differences were not observed in our study. However, there is
the risk of a type II error in our study due to the small sample size.
Another limitation of our study is that the asexual parasitemic
load was not measured. Further larger, preferably multicenter,
prospective studies are needed to conﬁrm whether co-infection is
more severe than the single infections alone. These studies should
take into consideration the confounding effects of different
Plasmodium species, DENV serotypes, and primary versus
secondary dengue infection.
In conclusion, our study highlights the importance of testing
for malaria in patients suspected of having dengue infection in
malaria endemic settings. The two infections are clinically
indistinguishable and speciﬁc diagnostic  testing is needed to
conﬁrm the diagnosis. The conﬁrmation of one infection should
not preclude the possibility of co-infection. The DEAG diagnostic
algorithm did not differentiate dengue from malaria infection.
We did not ﬁnd a statistically signiﬁcant between-group
difference in terms of severity of the disease using predeﬁned
criteria. Further well-designed prospective studies are needed to
understand the effect of co-infection on the severity of the
disease.
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